West Coast Financial’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-4,373
Closed -$367K 169
2024
Q3
$367K Buy
+4,373
New +$334K 0.04% 125
2023
Q1
Sell
-3,415
Closed -$293K 135
2022
Q4
$293K Buy
+3,415
New +$270K 0.05% 107
2019
Q2
Sell
-3,161
Closed -$205K 112
2019
Q1
$205K Buy
+3,161
New +$210K 0.05% 113
2018
Q4
Sell
-6,395
Closed -$494K 118
2018
Q3
$494K Buy
6,395
+1,045
+20% +$78.9K 0.11% 99
2018
Q2
$379K Sell
5,350
-232
-4% -$16.4K 0.1% 81
2018
Q1
$421K Hold
5,582
0.12% 82
2017
Q4
$400K Sell
5,582
-2,373
-30% -$180K 0.11% 86
2017
Q3
$645K Buy
7,955
+2,605
+49% +$199K 0.18% 87
2017
Q2
$379K Sell
5,350
-1,970
-27% -$131K 0.12% 88
2017
Q1
$497K Sell
7,320
-4,350
-37% -$306K 0.16% 87
2016
Q4
$836K Sell
11,670
-350
-3% -$26K 0.27% 73
2016
Q3
$951K Buy
+12,020
New +$976K 0.31% 71

Other funds holding GILD

West Coast Financial's GILD Position: Q4 2024 in Review

West Coast Financial sold out of Gilead Sciences (GILD) in Q4 2024, closing a stake of 4,373 shares — an estimated $367K sold.

West Coast Financial first reported a position in GILD in Q3 2016 and held it in 12 quarters. The position peaked at $951K in Q3 2016. 1,888 funds tracked by Wall St. Rank hold GILD as of Q4 2024.

  • West Coast Financial reported no remaining Gilead Sciences position as of Q4 2024 after selling out during the quarter.
  • West Coast Financial sold 4,373 Gilead Sciences shares in Q4 2024, an estimated $367K.
  • West Coast Financial first reported a position in Gilead Sciences in Q3 2016 and held it in 12 quarters.
  • West Coast Financial's Gilead Sciences position peaked at $951K in Q3 2016.
  • 1,888 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2024.

Based on West Coast Financial's 13F filing for Q4 2024, filed 15 Jan 2025.